Nymox Pharmaceutical Stock Price - NYMX

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$30.00
CHART Trader
Monthly Subscription
for only
$26.87
SMALL CAP PRO
Monthly Subscription
for only
$43.59
VAT not included
After Hours
Last Trade
Last: $ 4.40 ▼ -0.10 (-2.22%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Nymox Pharmaceutical Corp. (MM) NYMX NASDAQ Common Stock BSP733981026
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.15 -3.23% 4.50 4.68 4.41 4.68 4.65 20:00:00
Bid Price Ask Price Spread Spread % News
3.69 4.79 1.10 22.96% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
597 129,845 $ 4.4827 $ 582.06k 184.06k 1.62 - 5.79
Last Trade Time Type Quantity Stock Price Currency
19:56:10 formt 500 $4.40 USD

Nymox Pharmaceutical Corp. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 221.63M 49.25M $ -13.11M -0.28 0.00 28.29M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.42M $ 0.00 0.00% 50k 1.20%

more financials information »

Nymox Pharmaceutical Corp. (MM) News

Date Time Source News Article
3/31/201711:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)
3/29/201710:45GlobeNewswire Inc.Nymox Provides Update on Fexapotide Development
3/29/201710:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/29/201609:45GlobeNewswire Inc.Nymox Reports Additional Positive Results From Completed..
11/23/201615:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)
11/15/201613:56Edgar (US Regulatory)Report of Foreign Issuer (6-k)
10/11/201610:00GlobeNewswire Inc.Nymox Reports Successful New Phase 3 Long-Term Fexapotide..

Historical NYMX Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week4.424.754.380.000089k264k155k0.081.81%
1 Month3.244.753.150.000023k2M312k1.2638.89%
3 Months2.994.752.800.000022k2M192k1.5150.50%
6 Months3.264.752.670.000022k2M175k1.2438.04%
1 Year2.295.791.620.000014k18M503k2.2196.51%
3 Years5.195.790.320.0000028M530k-0.69-13.29%
5 Years7.928.52780.320.0000028M344k-3.42-43.18%

Nymox Pharmaceutical Corp. (MM) Description

Nymox Pharmaceutical Corporation is a biopharmaceutical company, engaged in R&D & sale of drugs for the aging population. It offers products such as AlzheimAlert™, NicAlert™ & TobacAlert™ & is developing NX-1207 for benign prostatic hyperplasia.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20170423 23:33:45